MicroRNA-4516-mediated regulation of <i>MAPK10</i> relies on 3' UTR <i>cis</i>-acting variants and contributes to the altered risk of Hirschsprung disease.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 32066630.
- Also identified by DOI 10.1136/jmedgenet-2019-106615 and PMC identifier 7877481.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hirschsprung disease (HSCR) is a life-threatening congenital disorder in which the enteric nervous system is completely missing from the distal gut. Recent studies have shown that miR-4516 markedly inhibits cell migration, and as one of its potential targets, <i>MAPK10</i> functions as a modifier for developing HSCR. We thus aimed to evaluate the role of miR-4516 and <i>MAPK10</i> in HSCR and how they contribute to the pathogenesis of HSCR. We examined 13 genetic variants using the MassArray system in a case-control study (n=1015). We further investigated miR-4516-mediated regulation of MAPK10 in HSCR cases and human neural cells, the effects of <i>cis</i>-acting elements in MAPK10 on miR-4516-mediated modulation and cell migration process. Three positive 3' UTR variants in <i>MAPK10</i> were associated with altered HSCR susceptibility. We also showed that miR-4516 directly regulates <i>MAPK10</i> expression, and this regulatory mechanism is significantly affected by the 3' UTR <i>cis</i>-acting elements of <i>MAPK10</i>. In addition, knock-down of <i>MAPK10</i> rescued the effect of miR-4516 on the migration of human neural cells. Our findings indicate a key role of miR-4516 and its direct target <i>MAPK10</i> in HSCR risk, and highlight the general importance of <i>cis</i>- and posttranscriptional modulation for HSCR pathogenesis.
Medical subject headings
- Genetic Predisposition to Disease
- Hirschsprung Disease
- MicroRNAs
- Mitogen-Activated Protein Kinase 10